These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28701467)

  • 1. The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.
    Brennan MJ; Tanner R; Morris S; Scriba TJ; Achkar JM; Zelmer A; Hokey DA; Izzo A; Sharpe S; Williams A; Penn-Nicholson A; Erasmus M; Stylianou E; Hoft DF; McShane H; Fletcher HA
    Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28701467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools for Assessing the Protective Efficacy of TB Vaccines in Humans:
    Tanner R; Satti I; Harris SA; O'Shea MK; Cizmeci D; O'Connor D; Chomka A; Matsumiya M; Wittenberg R; Minassian AM; Meyer J; Fletcher HA; McShane H
    Front Immunol; 2019; 10():2983. PubMed ID: 31998295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development.
    Pepponi I; Khatri B; Tanner R; Villarreal-Ramos B; Vordermeier M; McShane H
    Tuberculosis (Edinb); 2017 Sep; 106():118-122. PubMed ID: 28802398
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho SN
    Front Immunol; 2019; 10():896. PubMed ID: 31105706
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains.
    Painter H; Willcocks S; Zelmer A; Reljic R; Tanner R; Fletcher H
    Tuberculosis (Edinb); 2024 May; 146():102494. PubMed ID: 38367368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
    Marsay L; Matsumiya M; Tanner R; Poyntz H; Griffiths KL; Stylianou E; Marsh PD; Williams A; Sharpe S; Fletcher H; McShane H
    Tuberculosis (Edinb); 2013 Sep; 93(5):551-7. PubMed ID: 23726784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of the direct mycobacterial growth inhibition assay: a systematic review.
    Painter H; Harriss E; Fletcher HA; McShane H; Tanner R
    Front Immunol; 2024; 15():1355983. PubMed ID: 38380319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system.
    Yang AL; Schmidt TE; Stibitz S; Derrick SC; Morris SL; Parra M
    J Microbiol Methods; 2016 Dec; 131():7-9. PubMed ID: 27650198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUTI Vaccination Enhances Inhibition of Mycobacterial Growth
    Prabowo SA; Painter H; Zelmer A; Smith SG; Seifert K; Amat M; Cardona PJ; Fletcher HA
    Front Immunol; 2019; 10():894. PubMed ID: 31114572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy.
    Tanner R; O'Shea MK; Fletcher HA; McShane H
    Vaccine; 2016 Sep; 34(39):4656-4665. PubMed ID: 27527814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Tanner R; Hoogkamer E; Bitencourt J; White A; Boot C; Sombroek CC; Harris SA; O'Shea MK; Wright D; Wittenberg R; Sarfas C; Satti I; Verreck FAW; Sharpe SA; Fletcher HA; McShane H
    F1000Res; 2021; 10():257. PubMed ID: 33976866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans.
    Prabowo SA; Smith SG; Seifert K; Fletcher HA
    Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two mycobacterial strains in performance of the whole blood mycobacterial growth inhibition assay in Indian children.
    Venkataraman A; Shanmugam S; Balaji S; Mani K; Shanmugavel AK; Muthuramalingam K; Hissar S; Thiruvengadam K; Selladurai E; Smuk M; Hanna LE; Prendergast AJ
    Tuberculosis (Edinb); 2022 Dec; 137():102255. PubMed ID: 36252397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
    Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW
    PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional whole blood assay to measure viability of mycobacteria, using reporter-gene tagged BCG or M.Tb (BCGlux/M.Tb lux).
    Newton S; Martineau A; Kampmann B
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21946922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells.
    Tanner R; Smith SG; van Meijgaarden KE; Giannoni F; Wilkie M; Gabriele L; Palma C; Dockrell HM; Ottenhoff THM; McShane H
    J Immunol Methods; 2019 Jun; 469():1-10. PubMed ID: 30710562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.
    Parra M; Yang AL; Lim J; Kolibab K; Derrick S; Cadieux N; Perera LP; Jacobs WR; Brennan M; Morris SL
    Clin Vaccine Immunol; 2009 Jul; 16(7):1025-32. PubMed ID: 19458207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.
    Jensen C; Lindebo Holm L; Svensson E; Aagaard C; Ruhwald M
    Sci Rep; 2017 Jun; 7(1):2830. PubMed ID: 28588268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.